マルヤマ タクマ
丸山 拓真 所属 医学部 医学科 職種 助教 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | SENP1 and SENP2 regulate SUMOylation of amyloid precursor protein. |
掲載誌名 | 正式名:Heliyon 略 称:Heliyon ISSNコード:24058440/24058440 |
巻・号・頁 | 4(4),pp.e00601 |
著者・共著者 | Maruyama Takuma, Abe Yoichiro, Niikura Takako |
発行年月 | 2018/04 |
概要 | Amyloid β, a key molecule in the pathogenesis of Alzheimer's disease (AD), is produced from amyloid precursor protein (APP) by the cleavage of secretases. APP is SUMOylated near the cleavage site of β-secretase. SUMOylation of APP reduces amyloid β production, but its regulatory system is still unclear. SUMOylation, a modification at a lysine residue of a target protein, is mediated by activating, conjugating, and ligating enzymes and is reversed by a family of sentrin/SUMO-specific proteases (SENPs). Here, we found that both SENP1 and SENP2 induced de-SUMOylation of APP. Using quantitative PCR, we also found that expression of SENP1 but not SENP2 increased in an age-dependent manner only in female mice. The results of immunoblot analyses showed that the protein expression was consistent with the PCR results. Females, compared to males, have a higher incidence of AD in humans and show more aggressive amyloid pathology in AD mouse models. Our results provide a clue to understanding the role of SUMOylation in the sex difference in AD pathogenesis. |
DOI | 10.1016/j.heliyon.2018.e00601 |
PMID | 29862363 |